The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers "JPI-289"

Completed

Phase 1 Results N/A

Summary of Purpose

The purpose of this study in to evaluate safety, tolerability, pharmacokinetics of JPI-289 in healthy male subjects.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 June 2016.

1 Nov 2013 4 Nov 2013 1 Aug 2014 1 Sep 2014 1 Sep 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Endpoint: Pharmacokinetics/Dynamics Study
  • Intervention: Parallel Assignment

Contacts